Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shigenori E. Nagai"'
Autor:
Katsunori Tozuka, Pattama Wongsirisin, Shigenori E. Nagai, Yasuhito Kobayashi, Miki Kanno, Kazuyuki Kubo, Ken Takai, Kenichi Inoue, Hiroshi Matsumoto, Yoshihito Shimizu, Masami Suganuma
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract To understand the mechanism underlying metastasis, identification of a mechanism-based and common biomarker for circulating tumour cells (CTCs) in heterogenous breast cancer is needed. SET, an endogenous inhibitor of protein phosphatase 2A,
Externí odkaz:
https://doaj.org/article/ed41bad432af419a9baf36baf65e40ba
Autor:
Clifford A. Hudis, Jonas Bergh, Bernardo Leon Rapoport, Lee S. Schwartzberg, Patricia Gomez, Gerold Meinhardt, Henri Roché, Joshua Zhang, Frederico Costa, Patricia Maeda, Begoña Bermejo, L. Huang, Bohuslav Melichar, Claudio Zamagni, William J. Gradishar, Shigenori E. Nagai, László Mangel, Arlene Chan, Henry L. Gomez, José Baselga
Introduction Sorafenib is a multikinase inhibitor with antiangiogenic/antiproliferative activity. In this randomized, double-blind, placebo-controlled phase III trial, we assessed first- or second-line capecitabine with sorafenib or placebo in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beab6d3ec2a49c7065963a1432c679f5
https://europepmc.org/articles/PMC5699974/
https://europepmc.org/articles/PMC5699974/
Autor:
Shigenori E, Nagai
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a304717e2b6d3690296b6d77cd7a2fb
https://pubmed.ncbi.nlm.nih.gov/23350383
https://pubmed.ncbi.nlm.nih.gov/23350383
Autor:
Kei Kimizuka1 kkim@kasukabe-city-hosp.jp, Kenichi Inoue2, Shigenori E. Nagai2, Tsuyoshi Saito3, Satoko Nakano4, Kazushige Futsuhara5, Hirofumi Yamada6, Shiori Kaneko7, Takashi Sakurai8, Satoshi Hata9, Masafumi Kurosumi10
Publikováno v:
Journal of Nippon Medical School. 2019, Vol. 86 Issue 3, p165-171. 7p.